Send to

Choose Destination
JAMA Neurol. 2019 May 6. doi: 10.1001/jamaneurol.2019.0974. [Epub ahead of print]

The Final Nail in the Coffin of Disease Modification for Dopaminergic Therapies: The LEAP Trial.

Author information

UC Gardner Neuroscience Institute and Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio.

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center